| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
1801 |
| issn |
1525-0016 |
| issueIdentifier |
12 |
| pageRange |
1800-1801 |
| publicationName |
Molecular therapy : the journal of the American Society of Gene Therapy |
| startingPage |
1800 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d51cb4c0a539ea2cc47c4aa3a028038c |
| bibliographicCitation |
Kay MA. Selecting the Best AAV Capsid for Human Studies. Molecular Therapy. 2015 Dec;23(12):1800–1. doi: 10.1038/mt.2015.206. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e6730cc7c5225667620f3fe460f47e4 |
| date |
201512 |
| identifier |
https://doi.org/10.1038/mt.2015.206
https://pubmed.ncbi.nlm.nih.gov/26689120
https://pubmed.ncbi.nlm.nih.gov/PMC4700120 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1525-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21793 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Selecting the Best AAV Capsid for Human Studies |
| discusses |
http://id.nlm.nih.gov/mesh/M0408969 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D036022
http://id.nlm.nih.gov/mesh/D002213 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005822
http://id.nlm.nih.gov/mesh/D000229Q000235 |